TRPA1 and Alzheimer disease: In APP/PS1 transgenic mice, another mouse model of AD, knockout of TRPA1 impedes AD progression, as evidenced by improved behavioral function, decreased Aβ plaque deposition, and proinflammatory cytokine production.